CAS 154229-18-2
:Acetato di abiraterone
- (3)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate (Ester)
- (3Beta,8Xi,9Xi,14Xi)-17-(Pyridin-3-Yl)Androsta-5,16-Dien-3-Yl Acetate
- (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-yl acetate
- Abiraterone Acetate
- Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, acetate (ester), (3β)-
- Cb 7630
- Zytiga
Abiraterone Acetate
CAS:Formula:C26H33NO2Purezza:>98.0%(T)(HPLC)Colore e forma:White to Light yellow to Light orange powder to crystalPeso molecolare:391.56Abiraterone Acetate
CAS:Adrenal cortical hormones and their derivatives nesoiFormula:C26H33NO2Colore e forma:White Crystalline PowderPeso molecolare:391.25113Ref: IN-DA00362K
1g32,00€5g74,00€10g117,00€25g183,00€50g211,00€100g324,00€250g553,00€500gPrezzo su richiesta100mg25,00€250mg25,00€Abiraterone Acetate
CAS:Abiraterone Acetate (CB7630) is an androstene derivative that inhibits steroid 17-alpha-hydroxylase and is used as an antineoplastic agent.
Formula:C26H33NO2Purezza:99.69% - 99.82%Colore e forma:SolidPeso molecolare:391.55Abiraterone Acetate
CAS:Formula:C26H33NO2Colore e forma:White To Off-White SolidPeso molecolare:391.56Abiraterone acetate
CAS:Formula:C26H33NO2Purezza:≥ 98.0%Colore e forma:White to off-white powderPeso molecolare:391.55Abiraterone Acetate
CAS:Prodotto controllatoFormula:C26H33NO2Colore e forma:NeatPeso molecolare:391.55Abiraterone Acetate
CAS:Prodotto controllatoApplications Abiraterone acetate is a novel steroidal inhibitor of human Cytochrome P450 (17α-Hydroxylase-C17,20-lyase): potential agent for the treatment of prostatic cancer.
References Denis, L., et al.: Cancer, 72, 3888 (1993), Potter, G.A., et al.: J. Med. Chem., 38, 2463 (1995), Denmeade, S., et al.: Nat. Rev., 2, 389(2002), Scher, H., et al.: J. Clin. Oncol., 23, 8253 (2005),Formula:C26H33NO2Colore e forma:NeatPeso molecolare:391.55Abiraterone Acetate-d4
CAS:Prodotto controllatoApplications Labelled Abiraterone acetate is a novel steroidal inhibitor of human Cytochrome P450(17α-Hydroxylase-C17,20-lyase): potential agent for the treatment of prostatic cancer.
References Denis, L., et al.: Cancer, 72, 3888 (1993), Potter, G.A., et al.: J. Med. Chem., 38, 2463 (1995), Denmeade, S., et al.: Nat. Rev., 2, 389(2002), Scher, H., et al.: J. Clin. Oncol., 23, 8253 (2005),Formula:C26H29D4NO2Colore e forma:NeatPeso molecolare:395.57Abiraterone acetate
CAS:Prodotto controllatoCYP17 enzyme inhibitorFormula:C26H33NO2Purezza:Min. 98 Area-%Colore e forma:PowderPeso molecolare:391.55 g/molAbiraterone acetate - Bio-X ™
CAS:Prodotto controllatoAbiraterone is an antiandrogen drug used in the treatment of metastatic prostate cancer. It is a derivative of steroidal progesterone. This drug inhibits the enzyme CYP17 irreversibly, thus inhibiting the synthesis of androgen. It specifically inhibits the conversion of 17-hydroxyprognenolone to dehydroepiandrosterone to decrease serum levels of testosterone and other androgens.Formula:C26H33NO2Purezza:Min. 95%Colore e forma:PowderPeso molecolare:391.55 g/molAbiraterone acetate
CAS:Formula:C26H33NO2Purezza:95.0%Colore e forma:White to off-white powderPeso molecolare:391.555Chlorobutoxy Abiraterone-d8
CAS:Prodotto controllatoFormula:C28D8H30ClNOColore e forma:NeatPeso molecolare:448.113-Epiabiraterone-d4 Acetate
CAS:Prodotto controllatoFormula:C26H29D4NO2Colore e forma:NeatPeso molecolare:395.57











